Lv1
34 积分 2024-06-18 加入
Five-year survival and infectious complications of donor-derived CD7 CAR-T therapy in T-ALL
17小时前
待确认
Five-year survival and infectious complications of donor-derived CD7 CAR-T therapy in T-ALL
8天前
已完结
Global patterns of leukemia by subtype, age, and sex in 185 countries in 2022
23天前
已完结
Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor–T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1)
1个月前
已完结
Hemophagocytic Lymphohistiocytosis
1个月前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
1个月前
已完结
CD7 CAR T-Cell Therapy and Allogeneic HSCT
2个月前
已完结
Fratricide-resistant CD7-CAR T cells in T-ALL
2个月前
已完结
Fratricide-resistant CD7-CAR T cells in T-ALL
2个月前
已完结
Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia
2个月前
已完结
皖公网安备34019202002308
